Insights

Loading spinner
Gathering insights about ImmunoScape

ImmunoScape Tech Stack

ImmunoScape uses 8 technology products and services including Fastly, Modernizr, HubSpot, and more. Explore ImmunoScape's tech stack below.

  • Fastly
    Content Delivery Network
  • Modernizr
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Webpack
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Piwik
    System Analytics & Monitoring
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players

Media & News

ImmunoScape's Email Address Formats

ImmunoScape uses at least 1 format(s):
ImmunoScape Email FormatsExamplePercentage
First.Last@immunoscape.comJohn.Doe@immunoscape.com
49%
First.L@immunoscape.comJohn.D@immunoscape.com
1%
First@immunoscape.comJohn@immunoscape.com
1%
First.Last@immunoscape.comJohn.Doe@immunoscape.com
49%

Frequently Asked Questions

Where is ImmunoScape's headquarters located?

Minus sign iconPlus sign icon
ImmunoScape's main headquarters is located at 1 Scotts Road Singapore, SG. The company has employees across 3 continents, including AsiaNorth AmericaOceania.

What is ImmunoScape's official website and social media links?

Minus sign iconPlus sign icon
ImmunoScape's official website is immunoscape.com and has social profiles on LinkedIn.

How much revenue does ImmunoScape generate?

Minus sign iconPlus sign icon
As of July 2024, ImmunoScape's annual revenue reached $3.8M.

What is ImmunoScape's SIC code NAICS code?

Minus sign iconPlus sign icon
ImmunoScape's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ImmunoScape have currently?

Minus sign iconPlus sign icon
As of July 2024, ImmunoScape has approximately 43 employees across 3 continents, including AsiaNorth AmericaOceania. Key team members include Vice President Strategy: A. N.Founder Ceo & Chairman Of Board: C. C. N.Group Chief Financial Officer: R. C.. Explore ImmunoScape's employee directory with LeadIQ.

What industry does ImmunoScape belong to?

Minus sign iconPlus sign icon
ImmunoScape operates in the Biotechnology Research industry.

What technology does ImmunoScape use?

Minus sign iconPlus sign icon
ImmunoScape's tech stack includes FastlyModernizrHubSpotWebpackYoast SEOPiwikGoogle Tag ManagerYouTube.

What is ImmunoScape's email format?

Minus sign iconPlus sign icon
ImmunoScape's email format typically follows the pattern of . Find more ImmunoScape email formats with LeadIQ.

How much funding has ImmunoScape raised to date?

Minus sign iconPlus sign icon
As of July 2024, ImmunoScape has raised $14M in funding. The last funding round occurred on Sep 20, 2022 for $14M.

When was ImmunoScape founded?

Minus sign iconPlus sign icon
ImmunoScape was founded in 2016.
ImmunoScape

ImmunoScape

Biotechnology ResearchSingapore, Singapore11-50 Employees

ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.

To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.

Section iconCompany Overview

Headquarters
1 Scotts Road Singapore, SG
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $14M

    ImmunoScape has raised a total of $14M of funding over 4 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $14M.

  • $10M

    ImmunoScape's revenue is in the range of $10M

Section iconFunding & Financials

  • $14M

    ImmunoScape has raised a total of $14M of funding over 4 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $14M.

  • $10M

    ImmunoScape's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.